Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Assessed listed medicines (20)
- (-) Complementary medicines (17)
- Advertising (90)
- COVID-19 (65)
- Prescription medicines (60)
- Regulatory compliance (57)
- Therapeutic goods regulation (49)
- Non-prescription medicines (38)
- Listed medicines (36)
- Legislation (34)
- COVID-19 vaccines (30)
- Manufacturing (30)
- Vaping hub (24)
- Medicine safety (17)
- Labelling and packaging (16)
- Over the counter (OTC) medicines (13)
- Australian Register of Therapeutic Goods (ARTG) (11)
- Compliance and enforcement hub (10)
- In Vitro Diagnostic medical devices (IVDs) (10)
- Scheduling (national classification system) (10)
- Medicinal cannabis hub (8)
- Safety (7)
- Alert/Advisory (6)
- Import and export (6)
- Medical devices safety (6)
- Sunscreens (4)
- Weight loss products (4)
- Shortages (3)
- Advisory bodies and committees (2)
- Biological medicines (1)
- Blood and blood components (1)
- Cosmetics (1)
- Fees and payments (1)
Search
37 result(s) found, displaying 1 to 25
-
NewsWe will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement
-
NoticesUpdate on the progress in reducing the backlog of GMP Clearance Compliance Verification (CV) applications.
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025, which commenced on 1 March 2025
-
NoticesThis consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) which commenced on 27 September 2024.
-
NoticesInformation for manufacturers and sponsors regarding a new method for GMP inspections that will be used from 1 July 2024 and the extended validity of TGA issued GMP Certificates.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
NoticesWe've created a new GMP clearance Sponsor Information Dashboard (SID) to provide industry with current information about our processing times, workload and key messages. We have also updated our GMP clearance guidance.
-
News‘Haytox’ has not been approved by the TGA or included in the Australian Register of Therapeutic Goods (ARTG).
-
NewsFrom 30 November 2023, some sports supplements will be regulated as therapeutic goods and must be included in the Australian Register of Therapeutic Goods (ARTG).
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the latest Therapeutic Goods (Permissible Ingredients) Determination.
-
NewsThe TGA has updated the Australian Regulatory Guidelines for Sunscreens (ARGS) to align with the data requirements for all ingredients proposed to be included in the Therapeutic Goods (Permissible Ingredients) Determination
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2023.
-
NoticesMore applications for Good Manufacturing Practice (GMP) clearances can now be assessed under the TGA’s MRA pathway.
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2023.
-
Media releasesThe TGA has issued an infringement notice totalling $13,320 to Sydney company JSHealth Vitamins Pty Ltd for supplying a complementary medicine that allegedly did not conform with legal requirements.
-
NewsNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
-
NoticesThis instrument is made under subsection 26BD(3) of the Therapeutic Goods Act 1989.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Queensland-based individual for the alleged unlawful use of a prohibited representation and endorsement in advertising a listed complementary medicine.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2022.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
Pages
- Current page 1
- Page 2
- Next page Next ›
- Last page Last »